LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Home・Listă Acțiuni・Emergent BioSolutions Inc

Emergent BioSolutions Inc

Deschisă

Sector Sănătate

7.33 -6.86

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

7.13

Maxim

7.87

Indicatori cheie
By Trading Economics
Vânzări	6.1M 277M
EPS	-0.77
Angajați	1,600

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+52.48 upside

Statistici piață
By TradingEconomics
Capitalizare de piață	1.1M 121M
Deschiderea anterioară	14.19
Închiderea anterioară	7.33

Sentimentul știrilor

By Acuity

73%

27%

317 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

7.765 / 7.97 Suport & Rezistență

Emergent BioSolutions Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

12 mar. 2024, 15:10 UTC

Principalele dinamici ale pieței

Emergent BioSolutions Shares Drop on S&P Downgrade

Comparație

Modificare preț

Emergent BioSolutions Inc Așteptări

Obiectiv de preț

By TipRanks

52.48% sus

Prognoză pe 12 luni

Medie 12 USD 52.48%

Maxim 16 USD

Minim 8 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruEmergent BioSolutions Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 2 analiști care au acordat evaluări ale acțiunilor Emergent BioSolutions Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

7.765 / 7.97Suport & Rezistență

All events are bearish.

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

317 / 365 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Emergent BioSolutions Inc

Emergent BioSolutions Inc. is a life sciences company focused on providing civilian and military populations with a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). The Company is focused on five PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE); emerging infectious diseases (EID); travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). It operates through four business units, which includes three product business units: Vaccines, Devices, Therapeutics; and one services business unit: CDMO. The Company's contract development and manufacturing service offerings cover development services, drug substance manufacturing and drug product manufacturing across the pharmaceutical and biotechnology industries as well as the United States Government (USG) and non-Governmental organizations.